Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Traxion Sab De Cv Ord Shs GRPOF

Grupo Traxion SAB de CV is a Mexico-based company engaged in the transportation sector. The Company provides logistics services within eight business areas: Fright, including intermodal and multimodal services, door-to-door, national and cross-border distribution, among others; Integrated logistics, including logistics management, aerial and maritime services and custom transportation support services; Warehousing, including dedicated storage, shared warehouses, packing and value-added services, such as labeling and products assembly; Logistics systems, including software for logistics management; Passenger transportation, including transportation of personnel and students; Special services, including rental of bus and vans; Moving, including national and international moving services, and Advertising, including custom transportation services during marketing campaigns. The Company operates through a number of group companies.


PINL:GRPOF - Post by User

Comment by marketsenseon Nov 11, 2017 9:41pm
157 Views
Post# 26946449

RE:RE:Apotex

RE:RE:ApotexHi everyone.  I'm a new investor here and I am very impressed with the direction TBP is taking.
Doing FDA trials alone on the efficacy of MJ speaks volumes and is a much needed cachet
in recommending to MD's and Phm's that should serve TBP well.  There are so few entrants
in the medical side and therefore much less competition.  Retail LP producers are becoming
a dime a dozen just like the internet mom and pop website listings were when the PC/internet
revolution began.  TBP won't need to face stiff competition and therefore has a much greater
chance of capturing a patient orientated market.  I can see Aphria taking them out or some
other drug powerhouse at some point but I think there is some time yet to build shareholder
value.   I Don't think the market has quite appreciated what's been happening here and what 
TBP is all about because of the focus on the LP market.  As someone else stated,  at this
early stage of developement,  any sudden spikes in price will be accompanied by a corres
onding steep selloff which really doesn't do any good except for short term traders. Steady
and slow increases which are sustainable suits me fine.
                           
                                                           GLTA  MS
<< Previous
Bullboard Posts
Next >>